CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.56M | 5.59M | 11.43M | 10.74M | |
| Total Receivables | 405.00K | 224.00K | 364.00K | 440.00K | |
| Inventory | 540.00K | 573.00K | 553.00K | 673.00K | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 392.00K | 359.00K | 273.00K | 245.00K | |
| Total Current Assets | 3.90M | 6.75M | 12.62M | 12.09M | |
|
|
|||||
| Total Current Assets | 3.90M | 6.75M | 12.62M | 12.09M | |
| Net Property, Plant & Equipment | 3.17M | 3.89M | 4.58M | 4.88M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 45.00K | 73.00K | 102.00K | 116.00K | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 83.00K | 76.00K | 130.00K | 117.00K | |
| Total Assets | 7.20M | 10.79M | 17.44M | 17.21M | |
|
|
|||||
| Total Accounts Payable | 256.00K | 610.00K | 571.00K | 770.00K | |
| Total Accrued Expenses | 1.34M | 1.25M | 1.33M | 1.20M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 894.00K | 814.00K | 837.00K | 732.00K | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 2.49M | 2.67M | 2.74M | 2.70M | |
|
|
|||||
| Total Current Liabilities | 2.49M | 2.67M | 2.74M | 2.70M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 1.77M | 2.03M | 2.19M | 2.11M | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 4.25M | 4.70M | 4.93M | 4.81M | |
|
|
|||||
| Common Stock & APIC | 134.58M | 131.89M | 131.62M | 128.17M | |
| Retained Earnings | -130.66M | -124.84M | -118.15M | -114.80M | |
| Treasury Stock & Other | -969.00K | -969.00K | -969.00K | -969.00K | |
| Total Common Equity | 2.95M | 6.08M | 12.51M | 12.40M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 2.95M | 6.08M | 12.51M | 12.40M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 2.95M | 6.08M | 12.51M | 12.40M | |
|
|
|||||